Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and Therapeutics

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

Nonmammalian model systems of infection such as Galleria mellonella (caterpillars of the greater wax moth) have significant logistical and ethical advantages over mammalian models. In this study, we utilize G. mellonella caterpillars to study host-pathogen interactions with the gram-negative organism Acinetobacter baumannii and determine the utility of this infection model to study antibacterial efficacy. After infecting G. mellonella caterpillars with a reference A. baumannii strain, we observed that the rate of G. mellonella killing was dependent on the infection inoculum and the incubation temperature postinfection, with greater killing at 37 degrees C than at 30 degrees C (P = 0.01). A. baumannii strains caused greater killing than the less-pathogenic species Acinetobacter baylyi and Acinetobacter lwoffii (P < 0.001). Community-acquired A. baumannii caused greater killing than a reference hospital-acquired strain (P < 0.01). Reduced levels of production of the quorum-sensing molecule 3-hydroxy-C(12)-homoserine lactone caused no change in A. baumannii virulence against G. mellonella. Treatment of a lethal A. baumannii infection with antibiotics that had in vitro activity against the infecting A. baumannii strain significantly prolonged the survival of G. mellonella caterpillars compared with treatment with antibiotics to which the bacteria were resistant. G. mellonella is a relatively simple, nonmammalian model system that can be used to facilitate the in vivo study of host-pathogen interactions in A. baumannii and the efficacy of antibacterial agents.

Knowledge Graph

Similar Paper

Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and Therapeutics
Antimicrobial Agents and Chemotherapy 2009.0
Caenorhabditis elegans as a Model To Determine Fitness of Antibiotic-Resistant Salmonella enterica Serovar Typhimurium
Antimicrobial Agents and Chemotherapy 2007.0
Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii
Scientific Reports 2016.0
Determination of Antibiotic Efficacy against Bacillus anthracis in a Mouse Aerosol Challenge Model
Antimicrobial Agents and Chemotherapy 2007.0
Evaluation of Target Specificity of Antibacterial Agents Using Staphylococcus aureus ddlA Mutants and <scp>d</scp> -Cycloserine in a Silkworm Infection Model
Antimicrobial Agents and Chemotherapy 2009.0
11-Chloro-3-methyl-3H-imidazo[4,5-a]acridine (CMIA) as a potent and selective antimicrobial agent against clinical isolates of highly antibiotic-resistant Acinetobacter baumannii
Medicinal Chemistry Research 2012.0
Efficacy of Daptomycin against Bacillus anthracis in a Murine Model of Anthrax Spore Inhalation
Antimicrobial Agents and Chemotherapy 2010.0
Susceptibility of Acinetobacter Strains Isolated from Deployed U.S. Military Personnel
Antimicrobial Agents and Chemotherapy 2007.0
Using Bioluminescence To Monitor Treatment Response in Real Time in Mice with Mycobacterium ulcerans Infection
Antimicrobial Agents and Chemotherapy 2011.0
Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy 2010.0